27 July 2022: Meta-Analysis
The Prognostic Value of Periostin Expression in Non-Small Cell Lung Cancer: A Meta-Analysis
Mengjie Li 1234ABCDEFG* , Guangzhi Ma 1ABCDEF* , Xuebing Li 2ACFG* , Qinghua Zhou 12ACFG*DOI: 10.12659/MSM.936898
Med Sci Monit 2022; 28:e936898
Figure 2 Forest plots of overall outcomes for overall survival (OS). Hazard ratios (HRs) for each trial are represented by squares, and horizontal lines crossing the square show the 95% confidence intervals (CIs). The diamonds represent the estimated pooled effect of the overall outcome for OS in NSCLC. All P values are two-sided. STATA (version 13.1; Stata Corporation, College Station, TX, USA) was used.